- Home
- CELC vs GNTY Comparison
CELC vs GNTY Comparison
Compare CELC & GNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- GNTY
- Stock Information
- Founded
- CELC 2011
- GNTY 1913
- Country
- CELC United States
- GNTY United States
- Employees
- CELC N/A
- GNTY N/A
- Industry
- CELC Medical Specialities
- GNTY Major Banks
- Sector
- CELC Health Care
- GNTY Finance
- Exchange
- CELC Nasdaq
- GNTY Nasdaq
- Market Cap
- CELC 489.7M
- GNTY 407.7M
- IPO Year
- CELC 2017
- GNTY 2017
- Fundamental
- Price
- CELC $12.86
- GNTY $36.47
- Analyst Decision
- CELC Strong Buy
- GNTY Hold
- Analyst Count
- CELC 6
- GNTY 3
- Target Price
- CELC $29.17
- GNTY $36.67
- AVG Volume (30 Days)
- CELC 232.9K
- GNTY 23.7K
- Earning Date
- CELC 11-14-2024
- GNTY 01-14-2025
- Dividend Yield
- CELC N/A
- GNTY 2.62%
- EPS Growth
- CELC N/A
- GNTY N/A
- EPS
- CELC N/A
- GNTY 2.38
- Revenue
- CELC N/A
- GNTY $117,228,000.00
- Revenue This Year
- CELC N/A
- GNTY N/A
- Revenue Next Year
- CELC N/A
- GNTY $4.53
- P/E Ratio
- CELC N/A
- GNTY $15.44
- Revenue Growth
- CELC N/A
- GNTY N/A
- 52 Week Low
- CELC $11.51
- GNTY $27.01
- 52 Week High
- CELC $22.19
- GNTY $38.93
- Technical
- Relative Strength Index (RSI)
- CELC 42.58
- GNTY 50.86
- Support Level
- CELC $11.94
- GNTY $36.03
- Resistance Level
- CELC $13.14
- GNTY $37.01
- Average True Range (ATR)
- CELC 0.51
- GNTY 0.90
- MACD
- CELC 0.07
- GNTY -0.17
- Stochastic Oscillator
- CELC 58.70
- GNTY 26.73
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About GNTY Guaranty Bancshares Inc.
Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.